Abstract

BackgroundWomen with BRCA1/2 mutations are at high risk to develop breast and ovarian cancer. To support these women to participate in shared decision-making, structured nurse-led decision coaching combined with an evidence-based decision aid may be employed.In preparation of the interprofessional randomized controlled trial to evaluate a decision coaching program to support preventive decisions of healthy female BRCA 1/2 gene mutation carriers (EDCP-BRCA), we adapted and piloted an existing training program for specialized nurses and included elements from an existing physician communication training.MethodsThe training was adapted according to the six-step-approach for medical curriculum development. The educational design is based on experience- and problem-based learning.Subsequently, we conducted a qualitative pilot study. Nurses were recruited from six German centers for familial breast and ovarian cancer. The acceptability and feasibility were assessed by structured class observations, field notes and participants’ feedback. Data were analyzed using qualitative content analysis. The training was revised according to the results.Due to the COVID-19 pandemic, the patient intervention was adapted as a virtual coaching and a brief additional training for nurses was added.ResultsThe training consists of two modules (2 + 1 day) that teach competences in evidence-based medicine and patient information, (risk) communication and decision coaching. One pilot test was conducted with six nurses of which three were specialized and experienced in patient counselling. A final set of eight main categories was derived from the data: framework conditions; interaction; schedule, transparency of goals, content, methods, materials and practical relevance and feasibility. Overall, the training was feasible and comprehensible. Decision coaching materials were awkward to handle and decision coaching role plays were set too short. Therefore, materials will be sent out in advance and the training was extended.ConclusionsSpecialized nurses are rarely available and nurse-led counselling is not routinely implemented in the centers of familial breast and ovarian cancer. However, training of less qualified nurses seems feasible. Decision coaching in a virtual format seems to be a promising approach. Further research is needed to evaluate its feasibility, acceptability and effectiveness.Trial registrationThe main trial is registered under DRKS-ID: DRKS00015527.

Highlights

  • Women with BRCA1/2 mutations are at high risk to develop breast and ovarian cancer

  • Decision coaching in a virtual format seems to be a promising approach

  • Women with BRCA1/2 gene mutations have a cumulative risk of about 70% up to the age of 80 for breast cancer and about 44% (BRCA1) and 17% (BRCA2) for ovarian cancer [1]

Read more

Summary

Introduction

Women with BRCA1/2 mutations are at high risk to develop breast and ovarian cancer. To support these women to participate in shared decision-making, structured nurse-led decision coaching combined with an evidence-based decision aid may be employed. The lifetime risk of the general population is about 13 and 1% for breast and ovarian cancer respectively. To deal with these risks, healthy mutation carriers can decide between different options. These options comprise an intensified breast cancer-screening regimen, prophylactic surgeries, such as bilateral mastectomy and/or salpingo-oophorectomy, or to take no action at the moment. All options differ in their benefit-harm profiles [2,3,4,5,6,7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call